Sfoglia per Autore
Integrating network pharmacology: The next-generation approach in ocular drug discovery
2024-01-01 Lazzara, Francesca; Conti, Federica; Giuffrida, Erika; Eandi, Chiara Maria; Drago, Filippo; Platania, Chiara Bianca Maria; Bucolo, Claudio
Kinetic Perimetry on Virtual Reality Headset
2023-01-01 Terracciano, Rossana; Mascolo, Alice; Venturo, Laura; Guidi, Federica; Vaira, Mariangela; Eandi, Chiara M; Demarchi, Danilo
Brolucizumab in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: Ophthalmology and Diabetology Treatment Aspects
2023-01-01 Garweg, Justus G; Blum, Claudine A; Copt, René-Pierre; Eandi, Chiara M; Hatz, Katja; Prünte, Christian F; Seelig, Eleonora; Somfai, Gábor M
Influence of macular pigment on the sensitivity to discomfort glare from daylight
2023-01-01 Jain, Sneha; Wienold, Jan; Eandi, Chiara; Gisselbaek, Sara; Kawasaki, Aki; Andersen, Marilyne
Drug-Repurposing Strategy for Dimethyl Fumarate
2023-01-01 Giunta, Salvatore; D'Amico, Agata Grazia; Maugeri, Grazia; Bucolo, Claudio; Romano, Giovanni Luca; Rossi, Settimio; Eandi, Chiara M; Pricoco, Elisabetta; D'Agata, Velia
Central Retinal Vein Occlusion after COVID-19 Infection
2023-01-01 Nguyen, Ngoc-Chau Isabelle; Eandi, Chiara; Guex-Crosier, Yan
Clinical impact of the worldwide shortage of verteporfin (Visudyne®) on ophthalmic care
2022-01-01 Sirks M.J.; van Dijk E.H.C.; Rosenberg N.; Hollak C.E.M.; Aslanis S.; Cheung C.M.G.; Chowers I.; Eandi C.M.; Freund K.B.; Holz F.G.; Kaiser P.K.; Lotery A.J.; Ohno-Matsui K.; Querques G.; Subhi Y.; Tadayoni R.; Wykoff C.C.; Zur D.; Diederen R.M.H.; Boon C.J.F.; Schlingemann R.O.
Fluid dynamics between injections in incomplete anti-VEGF responders within neovascular age-related macular degeneration: a prospective observational study.
2022-01-01 Gigon A, Iskandar A, Eandi CM, Mantel I
Dosing Regimens of Intravitreal Aflibercept for Diabetic Macular Edema Beyond the First Year: VIOLET, a Prospective Randomized Trial.
2022-01-01 Garweg JG, Štefanickova J, Hoyng C, Niesen T, Schmelter T, Leal S, Sivaprasad S; Eandi CM; VIOLET Investigators.
Pathogenesis of Vascular Retinal Manifestations in COVID-19 Patients: A Review
2022-01-01 D'Alessandro E, Kawasaki A, Eandi CM.
WARE: Wet AMD Risk-Evaluation Tool as a Clinical Decision-Support System Integrating Genetic and Non-Genetic Factors.
2022-01-01 Fabrizio C, Termine A, Caputo V, Megalizzi D, Zampatti S, Falsini B, Cusumano A, Eandi CM, Ricci F, Giardina E, Strafella C, Cascella R.
Early Residual Fluid-Free Status and Long-Term BCVA Outcomes: A Treatment Agnostic, Post Hoc Analysis of Pooled HAWK and HARRIER Data
2022-01-01 Jhaveri, Chirag; Wykoff, Charles C; Khanani, Arshad M; Eandi, Chiara M; Chang, Andrew; B, Guruprasad; Gedif, Kinfemichael A; Singer, Michael
Early OCTA Changes of Type 3 Macular Neovascularization Following Brolucizumab Intravitreal Injections
2022-01-01 Gigon, Anthony; Vadalà, Maria; Bonfiglio, Vincenza M E; Reibaldi, Michele; Eandi, Chiara M
Bilateral acute macular neuroretinopathy following COVID-19 infection
2022-01-01 Giacuzzo, Clarice; Eandi, Chiara M; Kawasaki, Aki
TREATMENT DEFERRAL DURING COVID-19 LOCKDOWN: Functional and Anatomical Impact on Patients With Neovascular Age-Related Macular Degeneration
2022-01-01 Montesel A.; Gigon A.; Giacuzzo C.; Mantel I.; Eandi C.M.
Editorial: Ocular Pharmacology: Recent Breakthroughs and Unmet Needs
2022-01-01 Bucolo C.; Toro M.D.; Eandi C.M.
Inverted internal limiting membrane flap technique for macular hole coexistent with rhegmatogenous retinal detachment
2022-01-01 Stappler T.; Montesel A.; Konstantinidis L.; Wolfensberger T.J.; Eandi C.M.
Effects of circadian rhythm disruption on retinal physiopathology: Considerations from a consensus of experts.
2022-01-01 Parravano M, Eandi CM, Figus M, Lupidi M, Menchini F, Nicolo M, Parisi V, Toto L, Viola F, Vujosevic S, Querques G.
Short-Term Efficacy and Safety Outcomes of Brolucizumab in the Real-Life Clinical Practice
2021-01-01 Montesel A.; Bucolo C.; Sallo F.B.; Eandi C.M.
Treat and extend versus fixed regimen in neovascular age related macular degeneration: A systematic review and meta-analysis
2021-01-01 Fallico M.; Lotery A. J.; Longo A.; Avitabile T.; Bonfiglio V.; Russo A.; Castellino N.; Parisi G.; Pulvirenti A.; Eandi C.; Cennamo G.; Furino C.; Cicinelli M. V.; Alovisi C.; Reibaldi M.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Integrating network pharmacology: The next-generation approach in ocular drug discovery | 2024 | Lazzara, Francesca; Conti, Federica; Giuffrida, Erika; Eandi, Chiara Maria; Drago, Filippo; Platania, Chiara Bianca Maria; Bucolo, Claudio | |
| Kinetic Perimetry on Virtual Reality Headset | 2023 | Terracciano, Rossana; Mascolo, Alice; Venturo, Laura; Guidi, Federica; Vaira, Mariangela; Eandi, Chiara M; Demarchi, Danilo | |
| Brolucizumab in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: Ophthalmology and Diabetology Treatment Aspects | 2023 | Garweg, Justus G; Blum, Claudine A; Copt, René-Pierre; Eandi, Chiara M; Hatz, Katja; Prünte, Christian F; Seelig, Eleonora; Somfai, Gábor M | |
| Influence of macular pigment on the sensitivity to discomfort glare from daylight | 2023 | Jain, Sneha; Wienold, Jan; Eandi, Chiara; Gisselbaek, Sara; Kawasaki, Aki; Andersen, Marilyne | |
| Drug-Repurposing Strategy for Dimethyl Fumarate | 2023 | Giunta, Salvatore; D'Amico, Agata Grazia; Maugeri, Grazia; Bucolo, Claudio; Romano, Giovanni Luca; Rossi, Settimio; Eandi, Chiara M; Pricoco, Elisabetta; D'Agata, Velia | |
| Central Retinal Vein Occlusion after COVID-19 Infection | 2023 | Nguyen, Ngoc-Chau Isabelle; Eandi, Chiara; Guex-Crosier, Yan | |
| Clinical impact of the worldwide shortage of verteporfin (Visudyne®) on ophthalmic care | 2022 | Sirks M.J.; van Dijk E.H.C.; Rosenberg N.; Hollak C.E.M.; Aslanis S.; Cheung C.M.G.; Chowers I.; Eandi C.M.; Freund K.B.; Holz F.G.; Kaiser P.K.; Lotery A.J.; Ohno-Matsui K.; Querques G.; Subhi Y.; Tadayoni R.; Wykoff C.C.; Zur D.; Diederen R.M.H.; Boon C.J.F.; Schlingemann R.O. | |
| Fluid dynamics between injections in incomplete anti-VEGF responders within neovascular age-related macular degeneration: a prospective observational study. | 2022 | Gigon A, Iskandar A, Eandi CM, Mantel I | |
| Dosing Regimens of Intravitreal Aflibercept for Diabetic Macular Edema Beyond the First Year: VIOLET, a Prospective Randomized Trial. | 2022 | Garweg JG, Štefanickova J, Hoyng C, Niesen T, Schmelter T, Leal S, Sivaprasad S; Eandi CM; VIOLET Investigators. | |
| Pathogenesis of Vascular Retinal Manifestations in COVID-19 Patients: A Review | 2022 | D'Alessandro E, Kawasaki A, Eandi CM. | |
| WARE: Wet AMD Risk-Evaluation Tool as a Clinical Decision-Support System Integrating Genetic and Non-Genetic Factors. | 2022 | Fabrizio C, Termine A, Caputo V, Megalizzi D, Zampatti S, Falsini B, Cusumano A, Eandi CM, Ricci F, Giardina E, Strafella C, Cascella R. | |
| Early Residual Fluid-Free Status and Long-Term BCVA Outcomes: A Treatment Agnostic, Post Hoc Analysis of Pooled HAWK and HARRIER Data | 2022 | Jhaveri, Chirag; Wykoff, Charles C; Khanani, Arshad M; Eandi, Chiara M; Chang, Andrew; B, Guruprasad; Gedif, Kinfemichael A; Singer, Michael | |
| Early OCTA Changes of Type 3 Macular Neovascularization Following Brolucizumab Intravitreal Injections | 2022 | Gigon, Anthony; Vadalà, Maria; Bonfiglio, Vincenza M E; Reibaldi, Michele; Eandi, Chiara M | |
| Bilateral acute macular neuroretinopathy following COVID-19 infection | 2022 | Giacuzzo, Clarice; Eandi, Chiara M; Kawasaki, Aki | |
| TREATMENT DEFERRAL DURING COVID-19 LOCKDOWN: Functional and Anatomical Impact on Patients With Neovascular Age-Related Macular Degeneration | 2022 | Montesel A.; Gigon A.; Giacuzzo C.; Mantel I.; Eandi C.M. | |
| Editorial: Ocular Pharmacology: Recent Breakthroughs and Unmet Needs | 2022 | Bucolo C.; Toro M.D.; Eandi C.M. | |
| Inverted internal limiting membrane flap technique for macular hole coexistent with rhegmatogenous retinal detachment | 2022 | Stappler T.; Montesel A.; Konstantinidis L.; Wolfensberger T.J.; Eandi C.M. | |
| Effects of circadian rhythm disruption on retinal physiopathology: Considerations from a consensus of experts. | 2022 | Parravano M, Eandi CM, Figus M, Lupidi M, Menchini F, Nicolo M, Parisi V, Toto L, Viola F, Vujosevic S, Querques G. | |
| Short-Term Efficacy and Safety Outcomes of Brolucizumab in the Real-Life Clinical Practice | 2021 | Montesel A.; Bucolo C.; Sallo F.B.; Eandi C.M. | |
| Treat and extend versus fixed regimen in neovascular age related macular degeneration: A systematic review and meta-analysis | 2021 | Fallico M.; Lotery A. J.; Longo A.; Avitabile T.; Bonfiglio V.; Russo A.; Castellino N.; Parisi G.; Pulvirenti A.; Eandi C.; Cennamo G.; Furino C.; Cicinelli M. V.; Alovisi C.; Reibaldi M. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile